NCT05551091

Glycomacropeptide and Women's Health

Glycomacropeptide as a Protein Supplement to Curb Hunger

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 13 (actual)
• Sponsor: University of Wisconsin, Madison · Academic / Other
• Sex: Female
• Age: 90 Years
• Healthy volunteers: Accepted

Summary

This is a study about how a dietary supplement containing a whey protein affects hormones controlling hunger and satiety (leptin and ghrelin) in postmenopausal women with a body mass index between 28 and 35 kg/m2. Participants can expect to be in study for 4 weeks.

Detailed description

The purpose of this research study is to understand how a dietary supplement containing glycomacropeptide (GMP) affects blood sugar levels and hormones that regulate hunger and satiety. This study is being conducted to find new ways to help women lose weight and reduce their chance of getting diabetes.

Conditions

• Obesity

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	glycomacropeptide (GMP)	For each of the two baseline visits, women will consume a 300 calorie liquid breakfast meal tolerance test (MTT), eat a standard test lunch ad libitum with recording of food intake, and will then begin the low-dose GMP (25 g BID with meals) or high-dose GMP (25 g TID with meals) for 7 days. On day 7 of each GMP diet, women will come to the Clinical Research Unit (CRU) for a second breakfast MTT followed by lunch. All subjects will stop GMP products for 5-7 days (washout).

Timeline

• Start date: 2019-04-09
• Primary completion: 2022-07-05
• Completion: 2022-07-05
• First posted: 2022-09-22
• Last updated: 2022-10-03

Locations

1 site across 1 country: United States